The medicine is prescribed for adult patients with: 🔹 Type 2 diabetes mellitus: to improve glycemic control along with diet and exercise. 🔹 Excess weight and obesity: for effective weight management and reduction (as prescribed by a doctor). 🔹 Cardiovascular risk reduction: in patients with type 2 diabetes and established heart disease.

Dosage and administration

Packaging: 7 mg tablets. ⚠️ ADMINISTRATION PROTOCOL (CRUCIAL): Usual Dose: 7 mg is the **standard therapeutic dose**. Patients typically step up to this dose after 30 days on the 3 mg starting dose. Take 1 tablet once daily. Food Intake: Must be taken STRICTLY on an empty stomach, immediately upon waking up. How to take: Swallow the tablet whole with a small sip of plain water (up to 120 ml / 4 oz). Do not chew, crush, or split the tablet! Waiting time: After taking the tablet, you must wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medications. Storage (Important!): Tablets are highly sensitive to moisture. Do not remove the tablet from the blister pack ahead of time! Extract it right before swallowing. Store below 30°C.

Allergy to Semaglutide or any component of the product. Type 1 diabetes. Personal or family history of medullary thyroid carcinoma (MTC). Pregnancy and breastfeeding (stop treatment at least 2 months before a planned pregnancy). Severe gastrointestinal diseases.

Possible side effects (may temporarily increase when stepping up from 3 mg): 🤢 Digestive system: Nausea (most common), vomiting, diarrhea, abdominal pain, constipation. 📉 Metabolism: Decreased appetite (expected effect), possible hypoglycemia (if taken with other diabetes medications). 🤕 General: Fatigue, weakness. ⚠️ Important: If you experience severe, persistent abdominal pain that may radiate to your back (a possible sign of pancreatitis), stop taking the medicine and contact a doctor immediately.

Rybelsus 7 — Semaglutide 7 mg, 10 product-page.units_short, Novo Nordisk India

100% original product

Active ingredient

Semaglutide

Manufacturer

Novo Nordisk India

Dosage 7 mg

Dosage form Tablets

Tablets per pack 10

Rybelsus 7 (Semaglutide) 7 mg Tablets

Name: Rybelsus 7
Brand: Novo Nordisk India
SKU: PROD-122
Price: 2682 UAH
Availability: InStock

2682₴ ~~3298₴~~ -19%

Rybelsus 7 mg (Semaglutide) is an original, innovative medicine used for the treatment of type 2 diabetes and weight management.

Manufacturer: Novo Nordisk. Each pack contains 10 tablets (1 blister card). Belonging to the class of GLP-1 receptor agonists, it stimulates insulin production, lowers blood sugar levels, and significantly reduces appetite.

Key Features:

✅ Original medication from a global leader in diabetes care.
✅ The world's only oral semaglutide — a convenient alternative to injections (like Ozempic or Wegovy).
✅ Proven efficacy in weight reduction and blood sugar control.

The medicine is prescribed for adult patients with:

🔹 Type 2 diabetes mellitus: to improve glycemic control along with diet and exercise.
🔹 Excess weight and obesity: for effective weight management and reduction (as prescribed by a doctor).
🔹 Cardiovascular risk reduction: in patients with type 2 diabetes and established heart disease.

Packaging: 7 mg tablets.

⚠️ ADMINISTRATION PROTOCOL (CRUCIAL):

Usual Dose: 7 mg is the **standard therapeutic dose**. Patients typically step up to this dose after 30 days on the 3 mg starting dose. Take 1 tablet once daily.
Food Intake: Must be taken STRICTLY on an empty stomach, immediately upon waking up.
How to take: Swallow the tablet whole with a small sip of plain water (up to 120 ml / 4 oz). Do not chew, crush, or split the tablet!
Waiting time: After taking the tablet, you must wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medications.
Storage (Important!): Tablets are highly sensitive to moisture. Do not remove the tablet from the blister pack ahead of time! Extract it right before swallowing. Store below 30°C.

Allergy to Semaglutide or any component of the product.
Type 1 diabetes.
Personal or family history of medullary thyroid carcinoma (MTC).
Pregnancy and breastfeeding (stop treatment at least 2 months before a planned pregnancy).
Severe gastrointestinal diseases.

Possible side effects (may temporarily increase when stepping up from 3 mg):

🤢 Digestive system: Nausea (most common), vomiting, diarrhea, abdominal pain, constipation.
📉 Metabolism: Decreased appetite (expected effect), possible hypoglycemia (if taken with other diabetes medications).
🤕 General: Fatigue, weakness.
⚠️ Important: If you experience severe, persistent abdominal pain that may radiate to your back (a possible sign of pancreatitis), stop taking the medicine and contact a doctor immediately.